May 10, 2018
Lilly buys ARMO for $1.6 billion
Eli Lilly will buy ARMO BioSciences for $50 per share, or approximately $1.6 billion, the companies said Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: ARMO
Pharmaceuticals, Biotechnology and Life Sciences
Eli Lilly will buy ARMO BioSciences for $50 per share, or approximately $1.6 billion, the companies said Thursday.